FDA Advisory Committee Recommends Approval of Teva’s Asthma Biologic Reslizumab

FDA Advisory Committee Recommends Approval of Teva’s Asthma Biologic Reslizumab

Submitted by admin on December 10, 2015 - 11:18am
Source: 
Yahoo
News Tags: 
Teva Pharmaceutical
FDA
advisory panels
reslizumab
asthma
Headline: 
FDA Advisory Committee Recommends Approval of Teva’s Asthma Biologic Reslizumab

Do Not Allow Advertisers to Use My Personal information